Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

London pre-open: Stocks seen lower; NatWest in focus

(Sharecast News) - London stocks were set for a weaker open on Friday following a downbeat session on Wall Street, with earnings from NatWest in focus. The FTSE 100 was called to open 24 points lower at 7,668.

CMC Markets analyst Michael Hewson said: "As far as today's price action is concerned, the late decline in the US looks set to translate into a weaker European open, even though confidence is growing that the Fed is more or less done when it comes to its rate hiking cycle.

"Nonetheless, investors will be looking for further evidence of this with the latest core PCE deflator, as well as personal spending and income data for June, later this afternoon to support the idea of weaker inflation.

"Anything other than a PCE Core Deflator slowdown to 4.2% from 4.6%, could keep the prospect of a 25bps September hike on the table for a few weeks more. Both personal spending and income data are expected to improve to 0.4% and 0.5% respectively."

In UK corporate news, NatWest reported better-than-expected interim profits only days after it was rocked by the resignation of chief executive Alison Rose over the leaking of details of hard-right former political party leader Nigel Farage.

The bank posted pre-tax profit of £3.6bn, up from £2.6bn a year earlier and better than the £3.3bn estimated by analysts. It also announced a £500m share buyback.

Elsewhere, AstraZeneca reported a strong first half, driven by successful launches and effective commercial execution.

Excluding Covid-19 medicines, total revenue and product sales grew by 16% and 15%, respectively. The company also saw a 21% increase in core earnings per share, reaching $4.07, and maintained its interim dividend at 93 cents. AstraZeneca reaffirmed its full-year guidance for both total revenue and core earnings per share.

Share this article

Related Sharecast Articles

London open: Stocks gain ahead of US inflation; Experian surges
(Sharecast News) - London stocks rose in early trade on Wednesday, helped along by the likes of Experian and Imperial Brands, as investors eyed the latest US inflation reading.
London pre-open: Stocks seen up ahead of US CPI
(Sharecast News) - London stocks were set to rise at the open on Wednesday following a positive session on Wall street, as investors eyed the latest US inflation reading.
London close: Stocks manage gains as unemployment rises
(Sharecast News) - London stocks closed higher on Tuesday, as investors analysed the latest UK jobs data and remarks from Bank of England chief economist Huw Pill.
London midday: FTSE touch firmer after jobs data, Pill comments
(Sharecast News) - London stocks were still just a touch firmer by midday on Tuesday as investors mulled the latest jobs data and comments from Bank of England chief economist Huw Pill.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.